Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen, UCB say osteoporosis drug meets main goal in late-stage trial
Amgen, UCB say osteoporosis drug meets main goal in late-stage trial
Amgen, UCB say osteoporosis drug meets main goal in late-stage trial
Submitted by
admin
on February 22, 2016 - 9:40am
Source:
Yahoo/Reuters
News Tags:
Amgen
UCB Pharma
osteoporosis
clinical trials
romosozumab
Headline:
Amgen, UCB say osteoporosis drug meets main goal in late-stage trial
Do Not Allow Advertisers to Use My Personal information
